Artura Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2010.

2010 Chennai, Tamil Nadu, India Active

Last Updated: December 30, 2025

About Artura Pharmaceuticals Private Limited

Artura Pharmaceuticals Private Limited, a active private limited company, was established on 10 February 2010 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233TN2010PTC074560. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.77 Cr.

It upholds a compliant status. Employing 87 professional, Its leadership includes Pushpakala Harirajan (Director), Vikram Harirajan (Managing Director), Damodaram Harirajan (Director). Past directors included Vikram Harirajan. It holds ₹30.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.

Company Details

CIN/LLPIN
U24233TN2010PTC074560
Registration Number
074560
Incorporation Date
10 February 2010
Authorized Capital
₹5.00 Cr
Paid-Up Capital
₹4.77 Cr
ROC Code
Roc Chennai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 5.00 Cr as on 30-12-2025
Paid Up Capital ₹ 4.77 Cr as on 30-12-2025
Company Age 16 Year, 13 Days
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 30.22 Cr as on 30-12-2025
Revenue Growth **** 37.16% (FY 2024)
Profit Growth **** 770.50% (FY 2024)
Ebitda **** 30.40% (FY 2024)
Net Worth 179.14% (FY 2024)
Total Assets **** 16.76% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Artura Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Artura Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Pushpakala Harirajan	Director	10 Feb 2010	Current
Vikram Harirajan	Managing Director	10 Feb 2010	Current
Damodaram Harirajan	Director	10 Feb 2010	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	08 Aug 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Artura Pharmaceuticals.

Artura Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 37.16% increase. The company also saw a substantial improvement in profitability, with a 770.5% increase in profit. The company's net worth Soared by an impressive increase of 179.14%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

37.16%

*******

Revenue from Operations

*******

37.18%

*******

Total Assets

*******

16.76%

*******

Profit or Loss

*******

770.50%

*******

Net Worth

*******

179.14%

*******

EBITDA

*******

30.40%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Artura Pharmaceuticals?

In 2024, Artura Pharmaceuticals had a promoter holding of 48.37% and a public holding of 51.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹302,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Indian Overseas Bank : 30.22 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 May 2025	Indian Overseas Bank	₹1.20 M	Open
24 Sep 2021	Indian Overseas Bank	₹2.89 Cr	Open
22 Jul 2013	Indian Overseas Bank	₹27.21 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Artura Pharmaceuticals?

Artura Pharmaceuticals has a workforce of 87 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Artura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artura Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Artura Pharmaceuticals

Recent Activity within the Organization

Charges

The activity A charge with Indian Overseas Bank amounted to Rs. 0.12 Cr with Charge ID 101108856 was registered on 20 May 2025. was completed.
20 May 2025
Annual General Meeting

The activity Artura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
30 Sep 2024
Charges

A charge with Indian Overseas Bank of Rs. 27.21 Cr registered on 22 Jul 2013 with Charge ID 10439381 was modified on 31 Jul 2024. was recorded as a recent event.
31 Jul 2024
Balance Sheet

Artura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
31 Mar 2024
Charges

A charge with Indian Overseas Bank amounted to Rs. 2.89 Cr with Charge ID 100489805 was registered on 24 Sep 2021. was recorded as a recent event.
24 Sep 2021
Charges

The activity A charge with Indian Overseas Bank amounted to Rs. 27.21 Cr with Charge ID 10439381 was registered on 22 Jul 2013. was completed.
22 Jul 2013

Explore recent activity and updates - View Recent Activity